Ken Griffin acquired 14.1 Thousand Portage Biotech shares worth $3.82 Thousand. That's 0.00% of their equity portfolio (4942nd largest holding). The first Portage Biotech trade was made in Q2 2022. Since then Ken Griffin bought shares two more times and sold shares on two occasions. The investor's estimated purchase price is $23.5 Thousand, resulting in a loss of 84%.